News desk
Market news
Latest news about unlisted stock investment, from the original publishers.
Archive · 1,400 items
More coverage
National Commodity and Derivatives Exchange launches futures contract on the index NCDEX SOYDEX
Read original
PHARMEASY PARENT API HOLDINGS CLOCKS RS 60 CR EBITDA IN H1 FY24
Read original-
1mg pips PharmEasy in market share; what’s behind PayU’s new business forays?
-
CIAL registers 265.08cr net profit4
-
Apollo Global to Invest $125 m in Hero FinCorp for 9-11% Stake
-
IFFCO acquires 1.12% stake in NCDEX for about Rs.10 crores
-
PharmEasy Biggest Underperformer In Prosus’ India Portfolio In H1 FY24
-
PharmEasy’s scale crosses Rs 6,600 Cr in FY23; losses down 16%
-
India’s NCDEX to launch sunoil futures amid volatile prices
-
Pharmeasy FY23 losses widen 31%, revenue increases 16% to Rs 6,644 cr
-
CCI clears Ranjan Pai's proposal to acquire stake in PharmEasy
-
Hero Fincorp consolidated net profit rises 46.66% in the December 2022 quarter
-
Colombo Stock Exchange to get NCDEX help in commodity derivatives trading
-
PharmEasy raises $216 million at a 90% lower valuation from peak
-
PharmEasy raises $216M amid 90% valuation drop
-
NCDEX looking to develop commodity derivatives ecosystem in Iran, Nepal
-
PharmEasy valuation slashed to $458 Mn by Janus Henderson
-
PharmEasy halves loss to Rs 2,533 crore in FY24, revenue shrinks 15 per cent
-
Arohan Financial in talks with PEs to raise Rs 1,900 cr
-
Srinivasan, daughter Rupa return as promoters of CSK team owner
-
Kerala CM to inaugurate seven 'mega projects' at CIAL on October 2
-
Hero MotoCorp to invest upto Rs 700 cr in Hero FinCorp
-
NCDEX board approves launch of Equity and Equity Derivatives segments; plans investment of ₹400-600 crore